Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.
Moreno
Ana
A
Bárcena
Rafael
R
Quereda
Carmen
C
Casado
José L
JL
Pérez-Elías
María J
MJ
Fortún
Jesús
J
Nuño
Javier
J
Arranz
Isabel
I
Moreno
Santiago
S
D000141:Acidosis, Renal Tubular / Q000209:etiology; D058186:Acute Kidney Injury / Q000209:etiology; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D020123:Sirolimus / Q000008:administration & dosage*
D019428:HIV Integrase Inhibitors; D007166:Immunosuppressive Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D020123:Sirolimus